MedPath
HSA Approval

DORITHRICIN THROAT LOZENGES

SIN04392P

DORITHRICIN THROAT LOZENGES

DORITHRICIN THROAT LOZENGES

May 3, 1990

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Regulatory Information

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Therapeutic

Pharmacy Only

Formulation Information

LOZENGE

**Doses and administration** Unless otherwise prescribed by your physician, allow 1–2 lozenges to dissolve slowly in the mouth several times daily. The treatment should be continued for one day after the complaints have subsided.

ORAL

Medical Information

**Indications** Sore throat, stomatitis (inflammation of the mouth), pharyngitis (inflammation of the pharynx), laryngitis (inflammation of the larynx), gingivitis (inflammation of the gums).

**Contraindications** None known. Generally well-tolerated.

R02AA20

various

Manufacturer Information

HYPHENS PHARMA PTE. LTD.

Medice Arzneimittel Pütter GmbH & Co. KG

Active Ingredients

BENZALKONIUM CHLORIDE

1.0 mg

Benzalkonium

BENZOCAINE

1.5 mg

Benzocaine

TYROTHRICIN

0.5 mg

Tyrothricin

Documents

Patient Information Leaflets

Dorithricin Throat Lozenges PIL.pdf

Approved: September 25, 2018

Download
© Copyright 2025. All Rights Reserved by MedPath